Login to Your Account



AACR 2013

Better Therapeutic Index May Help Conquer Cell Division

By Anette Breindl
Science Editor

Wednesday, April 10, 2013
WASHINGTON– As far as cellular processes go, mitosis seems like a natural target for cancer drugs. "Its major business is cell growth," Genentech Inc.'s Peter Jackson told the audience at the annual meeting of the American Association for Cancer Research (AACR). It's got kinases – lots of kinases. And there is a "vast array" of traditional chemotherapies that hits some aspect of the cell cycle.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription